A synthetic tetrapeptide (Lys-Glu-Asp-Trp / KEDW) in the Khavinson short-peptide family, associated with pancreatic tissue. Reported in Russian preclinical studies to modulate pancreatic-islet function and glucose homeostasis. Part of the Cytogen class of ultra-short peptide bioregulators.
For research purposes only. Not medical advice.
Ruo Bio currently lists Pancragen at $1.15/mg, the lowest indexed price across 2 tracked research peptide vendors.
Pancragen ranges from $1.15/mg to $3.25/mg across 2 listings from 2 research peptide vendors, normalized to USD per milligram and refreshed daily.
2 research peptide vendors currently list Pancragen on PeptideScouter. We track 2 active listings across size and kit variants.